awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q50002199-FC3D51D6-35A4-4C93-8F7E-7B1EA8BFE071
Q50002199-FC3D51D6-35A4-4C93-8F7E-7B1EA8BFE071
BestRank
Statement
http://www.wikidata.org/entity/statement/Q50002199-FC3D51D6-35A4-4C93-8F7E-7B1EA8BFE071
Persistent prevention of oxaliplatin-induced peripheral neuropathy using calmangafodipir (PledOx®): a placebo-controlled randomised phase II study (PLIANT).
P2860
Q50002199-FC3D51D6-35A4-4C93-8F7E-7B1EA8BFE071
BestRank
Statement
http://www.wikidata.org/entity/statement/Q50002199-FC3D51D6-35A4-4C93-8F7E-7B1EA8BFE071
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
fc7f51c954528dc38d8b5ac09c3baf5c6b3b5511
P2860
Clinical Course of Oxaliplatin-Induced Neuropathy: Results From the Randomized Phase III Trial N08CB (Alliance).